This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Simone Oostindie, PhD
Scientist, Early Stage Translational Research at Genmab


Simone Oostindie is a Senior Scientist in the Translational Research team at Genmab. She holds an PhD degree in immunology from Leiden University and joined Genmab in 2014. She specializes in preclinical development of novel antibody therapeutics. Her current work focusses on translational research with respect to antibody biology, novel antibody technology platforms and next-generation antibody therapeutics.

Agenda Sessions

  • Avidity: A Rational Design Principle for Potentiated Antibody Therapeutics